BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6969652)

  • 1. [Colchicine sensitivity index: a means of distinguishing benign and malignant lymphocytic cutaneous infiltrates (author's transl)].
    Sterry W; Steigleder GK; Nikolai B
    Dtsch Med Wochenschr; 1980 Aug; 105(33):1157-9. PubMed ID: 6969652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated colchicine sensitivity of dermal lymphocytes in mycosis fungoides.
    Sterry W; Steigleder GK; Nikolai B
    Acta Derm Venereol; 1980; 60(3):257-9. PubMed ID: 6158230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ultrastructural morphometric and immunohistochemical analysis of cutaneous lymphomas and benign lymphocytic infiltrates of skin. Useful criteria for diagnosis.
    Payne CM; Grogan TM; Lynch PJ
    Arch Dermatol; 1986 Oct; 122(10):1139-54. PubMed ID: 3490225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thomson's colchicine test in differential diagnosis of lymphocytic leukemia and non-Hodgkin lymphoma].
    Skotnicki AB; Piastucka B; Zduńczyk A; Lisiewicz J
    Acta Haematol Pol; 1979 Oct; 10(4):299-306. PubMed ID: 539354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant lymphomas of the skin: their differentiation from lymphoid and nonlymphoid cutaneous infiltrates that simulate lymphoma.
    Burke JS
    Semin Diagn Pathol; 1985 Aug; 2(3):169-82. PubMed ID: 3916553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and therapy of cutaneous T-cell lymphomas].
    Le T; Pierard GE; Pierard-Franchimont C; de la Brassinne M; Lapière CM
    Dermatologica; 1984; 169(2):60-5. PubMed ID: 6332749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutaneous malignant lymphomata. Older ideas and newer concepts (author's transl)].
    Kresbach H
    MMW Munch Med Wochenschr; 1981 Aug; 123(35):1291-6. PubMed ID: 6793847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
    Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
    Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-cell lymphoma (author's transl)].
    Pathouli C; Michlmayr G; Huber C; Kurz R; Haas H; Huber H; Braunsteiner H
    Wien Klin Wochenschr; 1977 Jan; 89(2):45-9. PubMed ID: 139029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
    Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathomorphology of malignant skin lymphomas].
    Zabanova EV; Kazantseva IA; Kalamkarian AA
    Arkh Patol; 1987; 49(4):25-31. PubMed ID: 3496870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of malignant cutaneous lymphomas].
    Sterry W
    Dtsch Med Wochenschr; 1988 Feb; 113(5):184-9. PubMed ID: 3276493
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin.
    Evans HL; Winkelmann RK; Banks PM
    Cancer; 1979 Aug; 44(2):699-717. PubMed ID: 582573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunocytological study of cutaneous malignant lymphomas. Classification (author's transl)].
    Souteyrand P; Thivolet J; Alario A; Schmitt D; Perrot H
    Dermatologica; 1978; 157(5):268-81. PubMed ID: 150348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA flow cytometry from paraffin-embedded tissue in diagnosis of cutaneous malignant lymphomas and pseudolymphomas.
    Qiu BS; Ni HZ
    Chin Med J (Engl); 1993 Aug; 106(8):611-4. PubMed ID: 8222911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudolymphomatous cutaneous angiosarcoma: a rare variant of cutaneous angiosarcoma readily mistaken for cutaneous lymphoma.
    Requena L; Santonja C; Stutz N; Kaddu S; Weenig RH; Kutzner H; Menzel T; Cerroni L
    Am J Dermatopathol; 2007 Aug; 29(4):342-50. PubMed ID: 17667166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological diagnosis of cutaneous lymphomas. II. Membrane receptor for Helix pomatia lectin on lymphocytes: a new immunohistological marker for T-lymphocytes and Sezary cells].
    Trost TH
    Z Hautkr; 1985 Jan; 60(1-2):67-70. PubMed ID: 3885601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD7 expression in reactive and malignant human skin T-lymphocytes.
    Alaibac M; Pigozzi B; Belloni-Fortina A; Michelotto A; Saponeri A; Peserico A
    Anticancer Res; 2003; 23(3B):2707-10. PubMed ID: 12894562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.